Pulmonary Vascular Disease Flashcards

1
Q

2 pulmonary vascular diseases

A
  1. pulmonary embolism (PE)

2. pulmonary hypertension (PH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define PE and list out 2 types of PE

A

is thrombus formation in deep veins of the legs that break off and travel up to embolize in pulmonary arteries

  1. provoke - underlying condition/risk factor, unlikely to recur once the provoking factor is gone
  2. unprovoked - no underlying cause (or underlying cause not found), likely to recur and requires lifelong treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

thrombus vs blood clot

A
  • thrombus forms in moving blood, blood clot forms in stagnant blood
  • thrombus made out of RBCs, platelets, and fibrin
  • thrombus white/pale in color while blood clot is red/black
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

risk factors of PE

A
  • recent trauma, injury, fracture
  • recent surgery (bed bound)
  • cancer (increased clotting factors)
  • pregnant (increased clotting factors, fetus pressing on veins)
  • significant cardiopulmonary disease (heart failure)
  • inherited thrombophilia (V leiden gene)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

symptoms + signs of PE

A

SYMPTOMS:

  • pleuritic chest pain + cough + haemoptysis (when there is small embolus and necrosis)
  • isolated acute dyspnoea (when there are multiple small emboli)
  • syncope + cardiac arrest (when there is massive embolism in the main pulmonary artery)

SIGNS:

  • pyrexia (result of lung infarct)
  • pleural rub
  • stony/dull percussion
  • tachycardia/tachypnoea (important sign)
  • hypoxia
  • hypotension (from reduced CO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

scoring systems used in PE

A
  1. Wells score - based on symptoms and signs, used to determine likeliness of PE BEFORE diagnosis
  2. Revised geneva score - based on risk factors, symptoms, and signs (like HR)
  3. PESI score - based on age, comorbidity, physiological parameters (like age) - used AFTER PE diagnosis to risk stratify the patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

investigations in PE

* = main diagnosing test

A
  • *CT pulmonary angiogram (CTPA) (allows you to see pulmonary vessels)
  • V/Q scan (involves inhaling radioactive particles, used in ppl unfit for CTPA)
    • Echocardiogram (uses USS to show heart chambers, CO, detect pericardial effusion)
  • CXR
  • ECG
  • D-dimer (if -, not PE for sure, of +, could be PE or smth else)
  • blood test (biochem, full blood count)
  • TnI (troponin levels)
  • CT abdomen + mammography
  • thrombophilia testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treatment for PE

A
  • O2 (only use this if hypoxic)
  • low molecular weight heparin (LMWH) - dalteparin (injected, anticoagulant)
  • warfarin (oral anticoagulant, works by blocking formation of vit K dependent clotting factors)
  • direct oral anticoagulant - rivaroxaban, apixaban (most commonly used)
  • thrombolysis - alteplase (injected, used immediately after heart attack to improve survival, a type of tPA tissue plasminogen activator)
  • pulmonary embolectomy (only done in combination with anticoagulant therapy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the mech of tissue plasminogen activator?

A

formed a cleaved product called plasmin, which is an enzyme that dissolved plasma proteins including fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

define pulmonary hypertension and 2 types of PH

A
  • elevated bp in pulmonary arterial tree of > 25 mmHg
    1. primary PH: rare, 1-2/1 million, quickly progresses to death in young ppl
    2. secondary PH: more common, affects old people, slow-progressing and not fatal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cause of PH group 1

A

idiopathic:
- partial hypertension pf portal venous system (causes 1. cirrhosis, 2. embolism of portal vein)
- collagen vascular disease
- congenital heart disease
- HIV infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cause of PH group 2

A

secondary to left-sided heart disease:

- issue with mitral valve prolapse –> back flow of blood into the LA –> increased pulmonary arterial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cause of PH group 3

A

secondary to COPD

- damaged lung tissue –> hypoxia –> restricted pulmonary arteries –> pressure buildup that transfers to RV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cause of PH group 4

A

chronic thrombo-embolic pulmonary hypertension (CTEPH):

- webbing + scar tissue that narrows the arteries and result in high BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cause of PH group 5

A

sarcoidosis

- miscellaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

define portal venous system

A

veins coming from stomach, intestine, spleen, and pancreas and collecting in portal vein of the liver

17
Q

symptoms of PH

A

(not very specific)

  • exertion dyspnoea + syncope/presyncope (normally the heart would try to increase CO, but in PH this puts more pressure onto the already hard-working heart –> black out)
  • chest tightness
18
Q

signs of late stage PH

A
  • elevated JVP
  • right ventricular heave
  • loud S2 (from delayed pulmonary valve closure or early aortic valve closure)
  • hepatomegaly
  • ankle edema
19
Q

investigations for PH

A
  • CXR
  • ECG (not definitive)
  • Echo
  • V/Q scan
  • CTPA
  • right heart catheterization (same as Echo, but more direct measure of phulmonary arteries and CO)
20
Q

general treatment of PH

A
  • treat underlying cause in secondary PH
  • O2
  • anticoagulants
  • diuretics (for the excess fluid and edema)
21
Q

special treatment of PH

A
  • Ca channel antagonist (amlodipine) - single 10mg oral dose daily - pulmonary vasodilator for primary PH
  • prostacyclin
  • endothelin receptor antagonist (ERA) - bosetan, ambrisetan, macitentan - eliminates endothelin, which causes vasoconstriction
  • riociguat - oral soluble guanylate stimulator which stimulates the CO-sGC-cAMP pathway that improves lung capacity
  • phosphodiesterase inhibitor - sildenafil, tadalafil - prevent the breakdown of cAMP, resulting in decreased platelet activity
  • thromboendarterectomy - dissecting away scar tissue in recurrent PH
  • lung and heart transplant - worse case scenario
22
Q

what is the most commonly used drug in PH?

A

sildenafil (phophodiesterase inhibitor)